TCRX Tscan Therapeutics Inc
Company Analysis
Latest News
🔴 Tscan Therapeutics is trading 6% down in after-hours trading
Tscan Therapeutics is trading at $0.21, down 5.58% after-hours compared with the regular-session close; no clear company-specific catalyst was identified for...
🟢 Tscan Therapeutics is trading 5% up
Tscan Therapeutics is trading at $0.22, up 5.04%, with no clear company-specific announcement identified to explain the October 20 move. - A filing for the...
🟢 Tscan Therapeutics is trading 9% up in after-hours trading with no clear company-specific catalyst
Tscan Therapeutics is trading at $0.23, up 9.09%, with no clear company-specific announcement identified to explain its after-hours rise. - A recent filing...
🔴 Tscan Therapeutics is trading 5.6% down; cause remains unclear
Tscan Therapeutics is trading at $0.22, down 5.63%, with no clear cause identified as of 11:06 a.m. EST on October 19, 2026. - A recent proxy filing proposes a...
🟢 Tscan Therapeutics is trading 7.9% up in pre-market with no identified catalyst
Tscan Therapeutics is trading at $0.25, up 7.88%, in pre-market; no specific catalyst for the move was identified. - The latest company filing proposes a...
TScan Therapeutics Plans Reverse Stock Split, Facing Nasdaq Delisting Threat
TScan Therapeutics filed a preliminary proxy statement for a special stockholder meeting scheduled for November 20, 2026. The company seeks approval for a...
🟢 Tscan Therapeutics is trading 12% up today amid biotech-sector strength
Tscan Therapeutics is trading at $0.23, up 12.16%, amid supportive biotech-sector strength. - The biotech sector is up 2.20%, amid positive clinical news from...
🔴 Tscan Therapeutics is trading 7% down with no company-specific catalyst identified
Tscan Therapeutics is trading at $0.20, down 6.69%, amid likely broader risk-off pressure; no company-specific catalyst was identified. - September inflation...
🟢 Tscan Therapeutics is trading 5% up
Tscan Therapeutics is trading at $0.23, up 5.12%, with no clear company-specific catalyst identified for the October 14 move. - The Cellares manufacturing...
🟢 Tscan Therapeutics is trading 5% up in pre-market with no clear catalyst identified
Tscan Therapeutics is trading at $0.23, up 5.17% in pre-market on October 14, 2026, with no clear company-specific catalyst identified. - Tscan Therapeutics’...
🔴 Tscan Therapeutics is trading 10% down today amid biotech weakness
Tscan Therapeutics is trading at $0.21, down 10.47% on October 13, 2026, amid broader biotech weakness; no clear company-specific announcement explaining the...
🔴 Tscan Therapeutics is trading 6% down today with XBI down 2.01%
Tscan Therapeutics is trading at $0.22, down 5.80%, amid biotech weakness, though the sector decline does not establish the cause of its move. - Supplied...
🟢 Tscan Therapeutics is trading 6% up — reason remains unclear
Tscan Therapeutics is trading at $0.24, up 5.96%, but the reason for the gain remains unclear. - No fresh company-specific announcement was identified for...
🟢 Tscan Therapeutics is trading 9.29% up in pre-market — no clear company-specific catalyst identified
Tscan Therapeutics is trading at $0.25, up 9.29% in pre-market on October 9, with no clear company-specific announcement identified to explain the move. - A...
🔴 Tscan Therapeutics is trading 10.4% down today as biotech-sector weakness may contribute
Tscan Therapeutics is trading at $0.25, down 10.40%, with biotech-sector weakness a possible contributing factor; the available information does not establish...
🔴 Tscan Therapeutics is trading 5% down today alongside Nasdaq Composite's 0.54% decline
Tscan Therapeutics is trading 5.34% down at $0.26, alongside broader market weakness; no specific company catalyst was identified. - No company-specific...
🟢 Tscan Therapeutics is trading 5.3% up in after-hours trading with no clear company-specific catalyst identified
Tscan Therapeutics is trading at $0.29, up +5.30% after-hours, with no clear company-specific catalyst identified for the October 6 increase. - The company’s...
🔴 Tscan Therapeutics is trading 10.5% down with no clear catalyst identified
Tscan Therapeutics is trading 10.5% lower at $0.26, with no clear company-specific catalyst identified. - No new company-specific announcement or clear...
🔴 Tscan Therapeutics is trading 5.5% down amid biotech-sector weakness, with no clear catalyst
Tscan Therapeutics is trading 5.5% lower at $0.28 on October 6, 2026, with no clear company-specific catalyst identified. - The latest investor-relations...
🔴 Tscan Therapeutics is trading 10.45% down — no clear catalyst identified
Tscan Therapeutics is trading at $0.29, down 10.45%, with no clearly identified catalyst for the October 5, 2026 decline. - No new company announcement...